Nusantara Sawit Sejahtera Tbk. vs Prodia Diagnostic Line Tbk — how do they compare? Nusantara Sawit Sejahtera Tbk. trades at Rp800 (market cap 19.64T, 5.37M 24h volume), while Prodia Diagnostic Line Tbk trades at Rp236 (market cap 428.75B, 13.83M 24h volume). The key difference: Nusantara Sawit Sejahtera Tbk. is far larger — about 45.8× Prodia Diagnostic Line Tbk's market cap, and Prodia Diagnostic Line Tbk is more actively traded (13.83M versus 5.37M). Which is the better fit depends on your goals.
| NSSS | PRDL | |
|---|---|---|
Market Cap | 19.64T | 428.75B |
Volume | 5.37M | 13.83M |
Lot | 53.75K | 138.27K |
Turnover | 4.24B | 3.27B |
Average Price | 788.88 | 236.62 |
Value | 4.24B | 3.27B |
Indicative Equilibrium Price | 800 | 236 |
Indicative Equilibrium Volume | 537 | 1.74K |
Trailing returns across standard periods
Latest headlines on both assets
PT Nusantara Sawit Sejahtera Tbk (the Company) was established based on the Notarial DeedNo. 01 and No. 14 of Engawati Gazali, S.H., dated April 1, 2009 and June 12, 2009, respectively, and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia in its Decision Letter No. AHU-28662.AH.01.01 dated June 26, 2009. The Company started its commercialoperations in 2020.
Read more on NSSS →PT Prodia Diagnostic Line Tbk (the Company) was established April 16, 2010 with the name of PT DiaLine Systems Indonesia based on Notarial Deed No. 22 of Rismalena Kasri, S.H. On April 25, 2011, PT DiaLine Systems Indonesia changed the Companys name to PT Prodia Diagnostic Line based on Notarial Deed No. 14 of Rismalena Kasri, S.H. The Company is in the form of a Limited Liability Company in 2010 and began commercial production in 2011. The production results are marketed locally. The parent and ultimate parent entity of the Company is PT Prodia Utama.
Read more on PRDL →